drugset / Trial / NCT04236778
First-in-human Study of VE303 in Healthy Adult Volunteers
Non-randomizedSequentialOpen-labelOther
Summary
This study was designed to evaluate safety and tolerability of a range of doses of VE303 in healthy adult volunteers. The study also evaluated pharmacokinetics of intestinal colonization by the VE303 strains and pharmacodynamics of recovery of the gut microbiota after administration of antibiotics followed by a course of VE303.
Timeline
- Start
- 2017-11-28
- Primary completion
- 2019-03-11
- Completion
- 2019-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VE303 | Other / unclassified | — | — |
| Background | Vancomycin | Other / unclassified | — | Oral |
Indications
No indication recorded.